» Articles » PMID: 1374270

Localization of Transforming Growth Factor-beta at the Human Fetal-maternal Interface: Role in Trophoblast Growth and Differentiation

Overview
Journal Biol Reprod
Date 1992 Apr 1
PMID 1374270
Citations 79
Authors
Affiliations
Soon will be listed here.
Abstract

We examined the localization of transforming growth factor (TGF)-beta in first-trimester and term human decidua and chorionic villi and explored the role of this factor on the proliferation and differentiation of cultured trophoblast cells. Two antibodies, 1D11.16.8, a mouse monoclonal neutralizing antibody capable of recognizing both TGF-beta 1 and TGF-beta 2 and CL-B1/29, a rabbit polyclonal antibody capable of recognizing TGF-beta 2, were used to immunolocalize TGF-beta in fixed, paraffin-embedded, or fixed, frozen sections of placenta and decidua, providing similar results. Intense labeling was observed in the extracellular matrix (ECM) of the first-trimester decidua and cytoplasm of term decidual cells. Syncytiotrophoblast cell cytoplasm as well as the ECM in the core of the chorionic villi of both first-trimester and term placentas exhibited a moderate degree of labeling. Strong cytoplasmic labeling was observed in the cytotrophoblastic shell of the term placenta. To examine the role of TGF-beta on trophoblast proliferation and differentiation, early passage cultures of first-trimester and primary cultures of term trophoblast cells were established and characterized on the basis of numerous immunocytochemical and functional markers. These cells expressed cytokeratin, placental alkaline phosphatase, urokinase-type plasminogen activator, and pregnancy-specific beta glycoprotein, but not factor VIII or 63D3; they also produced hCG and collagenase type IV. Exposure of first-trimester trophoblast cultures to TGF-beta 1 significantly inhibited proliferation in a dose-dependent manner. An antiproliferative effect was also noted in the presence of TGF-beta 2. These effects were abrogated in the presence of the neutralizing anti-TGF-beta antibody (1D11.16.8) in a concentration-dependent manner. In a 3-day culture, exogenous TGF-beta 1 stimulated formation of multinucleated cells by the first trimester as well as term trophoblast cells. Addition of neutralizing anti-TGF-beta antibody to first-trimester trophoblast cells stimulated proliferation beyond control levels in a 24-h culture and reduced formation of multinucleated cells in a 3-day culture, indicating the presence of endogenous TGF-beta activity. These results indicate that TGF-beta produced at the human fetal-maternal interface plays a major regulatory role in the proliferation and differentiation of the trophoblast.

Citing Articles

Decoding the molecular pathways governing trophoblast migration and placental development; a literature review.

Liu L, Tang L, Chen S, Zheng L, Ma X Front Endocrinol (Lausanne). 2024; 15:1486608.

PMID: 39665023 PMC: 11631628. DOI: 10.3389/fendo.2024.1486608.


Insights into Reproductive Immunology and Placental Pathology.

Szukiewicz D Int J Mol Sci. 2024; 25(22.

PMID: 39596208 PMC: 11594814. DOI: 10.3390/ijms252212135.


Uterine macrophages and NK cells exhibit population and gene-level changes after implantation but maintain pro-invasive properties.

Mani S, Garifallou J, Kim S, Simoni M, Huh D, Gordon S Front Immunol. 2024; 15:1364036.

PMID: 38566989 PMC: 10985329. DOI: 10.3389/fimmu.2024.1364036.


The Role of TGF-β during Pregnancy and Pregnancy Complications.

Wen B, Liao H, Lin W, Li Z, Ma X, Xu Q Int J Mol Sci. 2023; 24(23).

PMID: 38069201 PMC: 10706464. DOI: 10.3390/ijms242316882.


Molecular pathways in placental-fetal development and disruption.

Adibi J, Zhao Y, Koistinen H, Mitchell R, Barrett E, Miller R Mol Cell Endocrinol. 2023; 581:112075.

PMID: 37852527 PMC: 10958409. DOI: 10.1016/j.mce.2023.112075.